Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Rat|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Purified receptor for the C3d fragment of the third complement component CR2.|
|Storage buffer||tissue culture supernatant|
|Storage Conditions||4° C, do not freeze|
|Tested Applications||Dilution *|
|Immunohistochemistry (Frozen) (IHC (F))||1:10-1:25|
|Immunohistochemistry (Paraffin) (IHC (P))||1:10-1:25|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Western Blot (WB)||See 1 publications below|
MA1-27120 detects CD21 from human samples.
MA1-27120 has been successfully used in immunohistochemistry (paraffin, frozen) procedures.
The MA1-27120 immunogen is purified receptor for the C3d fragment of the third complement component CR2.
This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo.
MA1-27120 was used in western blot to study the inhibition of C6 glioma cell growth by caffeic acid phenethyl ester and the potential mechanisms involved
|Kuo HC,Kuo WH,Lee YJ,Lin WL,Chou FP,Tseng TH||Cancer letters (234:199)||2006|
complement C3d receptor; complement component (3d/Epstein Barr virus) receptor 2; complement receptor type 2; EBV receptor; epstein-Barr virus receptor
C3DR; CD21; CR; CR2; CVID7; SLEB9